- Home
- CTMX vs NML Comparison
CTMX vs NML Comparison
Compare CTMX & NML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- NML
- Stock Information
- Founded
- CTMX 2008
- NML 2012
- Country
- CTMX United States
- NML United States
- Employees
- CTMX N/A
- NML N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- NML Finance/Investors Services
- Sector
- CTMX Health Care
- NML Finance
- Exchange
- CTMX Nasdaq
- NML Nasdaq
- Market Cap
- CTMX 596.2M
- NML 488.4M
- IPO Year
- CTMX 2015
- NML N/A
- Fundamental
- Price
- CTMX $3.32
- NML $8.17
- Analyst Decision
- CTMX Strong Buy
- NML
- Analyst Count
- CTMX 5
- NML 0
- Target Price
- CTMX $5.80
- NML N/A
- AVG Volume (30 Days)
- CTMX 3.0M
- NML 219.3K
- Earning Date
- CTMX 11-07-2025
- NML 01-01-0001
- Dividend Yield
- CTMX N/A
- NML 9.75%
- EPS Growth
- CTMX 263.20
- NML N/A
- EPS
- CTMX 0.49
- NML N/A
- Revenue
- CTMX $141,100,000.00
- NML N/A
- Revenue This Year
- CTMX N/A
- NML N/A
- Revenue Next Year
- CTMX N/A
- NML N/A
- P/E Ratio
- CTMX $6.79
- NML N/A
- Revenue Growth
- CTMX 18.01
- NML N/A
- 52 Week Low
- CTMX $0.40
- NML $6.09
- 52 Week High
- CTMX $3.91
- NML $7.33
- Technical
- Relative Strength Index (RSI)
- CTMX 55.87
- NML 41.32
- Support Level
- CTMX $3.21
- NML $7.89
- Resistance Level
- CTMX $3.91
- NML $8.37
- Average True Range (ATR)
- CTMX 0.26
- NML 0.19
- MACD
- CTMX -0.06
- NML -0.00
- Stochastic Oscillator
- CTMX 30.59
- NML 35.44
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About NML Neuberger Berman Energy Infrastructure and Income Fund Inc.
Neuberger Berman Energy Infrastructure & Income Fund Inc is a closed-end investment management company based in the United States. Invest in Capital Markets, Chemicals, Oil, Gas & Consumable Fuels, Electric Utilities, Independent Power and Renewable Electricity Producers, Multi Utilities. Maximum is done in Oil, Gas & Consumable Fuels.